|
A more recent version of this article appeared on February 1, 2004
Papers In Press, published online ahead of print November 1, 2003
J. Lipid Res., doi:10.1194/jlr.M300232-JLR200
Submitted on May 29, 2003
Revised on October 10, 2003
Accepted on October 24, 2003
Formation of 7-dehydrocholesterol-containing membrane rafts in vitro and in vivo, with relevance to the Smith-Lemli-Opitz syndrome
R. Kennedy Keller, Thomas P. Arnold, and Steven J. Fliesler
Saint Louis University Eye Institute and Ophthalmology, Saint Louis University, Saint Louis, MO 63104-1540
Corresponding Author: fliesler{at}slu.edu
Smith-Lemli-Opitz Syndrome (SLOS) is a recessive disease typified by 7-dehydrocholesterol (7DHC) accumulation and depletion of cholesterol (CHOL). Since CHOL is a primary component of detergent-resistant membrane domains (rafts), we examined the compatibility of 7DHC with raft formation. Liposomes containing bovine brain phosphatidylcholine, sphingomyelin, cerebrosides, and either CHOL, 7DHC, or coprostanol (the latter being incompatible with raft formation) were prepared. 7DHC was indistinguishable from CHOL in its ability to become incorporated into membrane rafts, as judged by physical and chemical criteria, whereas coprostanol did not form rafts. The in vivo compatibility of 7DHC with raft formation was evaluated in brains of rats treated with AY9944, which mimics the SLOS biochemical defect. 7DHC/CHOL ratios in rafts and whole brains from AY9944-treated rats were similar, indicating comparable efficiency of 7DHC and CHOL incorporation into brain rafts. In contrast, dolichol (a non-sterol isoprenoid incompatible with raft formation) was greatly depleted in brain rafts, relative to whole brain. Although brain raft fractions prepared from AY9944-treated and control rats yielded similar sterol/protein ratios, their gel electrophoresis profiles exhibited multiple differences, suggesting that altered raft sterol composition perturbs raft protein content. These results are discussed in the context of the SLOS phenotype, particularly as regards the associated central nervous system defects.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Sabatini, J.-P. Mattila, and P. K. J. Kinnunen
Interfacial Behavior of Cholesterol, Ergosterol, and Lanosterol in Mixtures with DPPC and DMPC
Biophys. J.,
September 1, 2008;
95(5):
2340 - 2355.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Laloi, A.-M. Perret, L. Chatre, S. Melser, C. Cantrel, M.-N. Vaultier, A. Zachowski, K. Bathany, J.-M. Schmitter, M. Vallet, et al.
Insights into the Role of Specific Lipids in the Formation and Delivery of Lipid Microdomains to the Plasma Membrane of Plant Cells
Plant Physiology,
January 1, 2007;
143(1):
461 - 472.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Pappu, W. E. Connor, L. S. Merkens, J. M. Jordan, J. A. Penfield, D. R. Illingworth, and R. D. Steiner
Increased nonsterol isoprenoids, dolichol and ubiquinone, in the Smith-Lemli-Opitz syndrome: effects of dietary cholesterol
J. Lipid Res.,
December 1, 2006;
47(12):
2789 - 2798.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Jiang and G. E. Herman
Analysis of Nsdhl-deficient embryos reveals a role for Hedgehog signaling in early placental development
Hum. Mol. Genet.,
November 15, 2006;
15(22):
3293 - 3305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Megha, O. Bakht, and E. London
Cholesterol Precursors Stabilize Ordinary and Ceramide-rich Ordered Lipid Domains (Lipid Rafts) to Different Degrees: IMPLICATIONS FOR THE BLOCH HYPOTHESIS AND STEROL BIOSYNTHESIS DISORDERS
J. Biol. Chem.,
August 4, 2006;
281(31):
21903 - 21913.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kovarova, C. A. Wassif, S. Odom, K. Liao, F. D. Porter, and J. Rivera
Cholesterol deficiency in a mouse model of Smith-Lemli-Opitz syndrome reveals increased mast cell responsiveness
J. Exp. Med.,
May 15, 2006;
203(5):
1161 - 1171.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Gondre-Lewis, H. I. Petrache, C. A. Wassif, D. Harries, A. Parsegian, F. D. Porter, and Y. P. Loh
Abnormal sterols in cholesterol-deficiency diseases cause secretory granule malformation and decreased membrane curvature.
J. Cell Sci.,
May 1, 2006;
119(Pt 9):
1876 - 1885.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kim, M. C. Gondre-Lewis, I. Arnaoutova, and Y. P. Loh
Dense-Core Secretory Granule Biogenesis
Physiology,
April 1, 2006;
21(2):
124 - 133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. N. Tulenko, K. Boeze-Battaglia, R. P. Mason, G. S. Tint, R. D. Steiner, W. E. Connor, and E. F. Labelle
A membrane defect in the pathogenesis of the Smith-Lemli-Opitz syndrome
J. Lipid Res.,
January 1, 2006;
47(1):
134 - 143.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A Woollett
Maternal cholesterol in fetal development: transport of cholesterol from the maternal to the fetal circulation
Am. J. Clinical Nutrition,
December 1, 2005;
82(6):
1155 - 1161.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Fernandez, M. Martin, D. Gomez-Coronado, and M. A. Lasuncion
Effects of distal cholesterol biosynthesis inhibitors on cell proliferation and cell cycle progression
J. Lipid Res.,
May 1, 2005;
46(5):
920 - 929.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K. Keller, M. Small, and S. J. Fliesler
Enzyme blockade: a nonradioactive method to determine the absolute rate of cholesterol synthesis in the brain
J. Lipid Res.,
October 1, 2004;
45(10):
1952 - 1957.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|